by Matthew Cote, MD, FACEP As the first two major vaccinations for COVID-19 have started to be widely distributed in the United States, a disturbing trend is emerging: many healthcare workers who presumably are educated about the vaccine, are declining to receive it. While not unanticipated, the degree to which it is occurring among healthcare providers is concerning. The numbers are not trivial, with up to 40% of some healthcare workers declining the opportunity to get vaccinated as reported recently in the LA Times, Forbes, and AP News. …
Read More →
by Richard B. Gibson Ensuring that healthcare resources are made available to those in the greatest need of them – be that individuals, groups, populations, or countries – is not only a matter of public health but also one of ethics. A failure to implement appropriate resources allocation, reflective of a situation’s specific demands, illustrates not only an ignorance of public health factors but also betrays ethical shortcomings.…
Read More →
How can AI potentially provide insight into how we understand biological systems? What factors do we need to consider for such an integration? Natural-language processing algorithms now may help read new virus mutations, especially helpful with #COVID19.
http://ow.ly/TAwi50D9Sy4
A big component of vaccine distribution has been utilizing ethics to determine vaccine prioritization. @IChotiner of The New Yorker speaks with immunologist Barry Bloom to discuss what goes into making decisions on vaccine distribution. #bioethics.
http://ow.ly/rlC750D9S3i
"The first year of the Covid-19 pandemic revealed that a country’s wealth would not spare it from the virus. Overconfidence, poor planning and ignored warnings felled the world’s richest nations. But now, money is translating into undeniable advantages."
http://ow.ly/l98D50D5nUt
Target Article on multi-omic privacy is out in AJOB @bioethics_net. Profoundly grateful to my brilliant collaborator Eline M. Bunnik @ErasmusMC for hard work and tenacity on this one. We look forward to reading open peer commentaries! @genomics_policy https://www.tandfonline.com/doi/full/10.1080/15265161.2020.1863516
With efficacious medications available, ethics considers who has access to these drugs and who is at risk of losing them. Under #COVID19, there has been an increase in "pharmacy deserts", where people struggle to fill medications locally. #bioethics
https://www.axios.com/pharmacy-deserts-cities-prescriptions-45c32271-37ac-4105-b1bb-e2d2436b88c1.html
